← Leaderboards
Changiz Geula
Beth Israel Deaconess Medical Center
$15,193,529
Attributed
$23,895,872
Total exposure
18
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$42,950,986 · 19
By mechanism
U19$25,507,785 · 5
R01$12,968,915 · 5
R56$1,380,437 · 1
R24$1,058,025 · 1
P30$960,482 · 1
R21$810,483 · 2
Top collaborators
- Marek-Marsel M Mesulam28 shared
- Emily J Rogalski27 shared
- Tamar D Gefen1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Thomas T Perls$63,319,794
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseInvestigationBrainNeuronsResearch PersonnelNeuropathologyDementiaPhenotypeAgingGeneticBehavioralSynapsesAnatomyBrain TissueAge RelatedAutopsyPathologicElderlyPatternMultidisciplinaryCognitionMolecularBase
Grant awards (64)
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$2,858,489
U19 · FY2025 · AG
Core-003$2,070,423
U19 · FY2025 · AG
Admin-Core-003$788,066
U19 · FY2025 · AG
Anatomic, Pathologic, and Molecular Signatures of FTLD-TDP type C$786,632
R01 · FY2025 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$673,808
R01 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$403,457
U19 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$105,096
U19 · FY2025 · AG
Research Education Component$94,371
P30 · FY2025 · AG · contact PI
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$83,006
U19 · FY2025 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$3,562,822
U19 · FY2024 · AG
Core-003$737,827
U19 · FY2024 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$667,921
R01 · FY2024 · NS · contact PI
Admin-Core-003$381,203
U19 · FY2024 · AG
Biospecimen/Neuropathology Core$343,913
U19 · FY2024 · AG · contact PI
Research Education Component$135,651
P30 · FY2024 · AG · contact PI
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$2,660,591
U19 · FY2023 · AG
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$1,279,463
U19 · FY2023 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$747,866
R01 · FY2023 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$667,921
R01 · FY2023 · NS · contact PI
Core-003$404,003
U19 · FY2023 · AG
Biospecimen/Neuropathology Core$232,068
U19 · FY2023 · AG · contact PI
Admin-Core-003$200,071
U19 · FY2023 · AG
Biospecimen/Neuropathology Core$172,145
U19 · FY2023 · AG · contact PI
Research Education Component$120,646
P30 · FY2023 · AG · contact PI
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$3,972,149
U19 · FY2022 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$751,796
R01 · FY2022 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$667,921
R01 · FY2022 · NS · contact PI
Biospecimen/Neuropathology Core$559,849
U19 · FY2022 · AG · contact PI
Research Education Component$135,651
P30 · FY2022 · AG · contact PI
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)$4,130,041
U19 · FY2021 · AG
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$748,297
R01 · FY2021 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$667,921
R01 · FY2021 · NS · contact PI
Biospecimen/Neuropathology Core$563,103
U19 · FY2021 · AG · contact PI
Research Education Component$474,163
P30 · FY2021 · AG · contact PI
Characterized Adult Primary Human Microglia Cells for Research$260,076
R24 · FY2021 · NS · contact PI
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease$759,391
R01 · FY2020 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$685,581
R01 · FY2020 · NS · contact PI
Characterized Adult Primary Human Microglia Cells for Research$266,102
R24 · FY2020 · NS · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$1,380,437
R56 · FY2019 · AG
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$351,038
R01 · FY2019 · AG
Characterized Adult Primary Human Microglia Cells for Research$262,957
R24 · FY2019 · NS · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$444,140
R01 · FY2018 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$337,969
R01 · FY2018 · NS · contact PI
Characterized Adult Primary Human Microglia Cells for Research$268,890
R24 · FY2018 · NS · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$444,140
R01 · FY2017 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$337,969
R01 · FY2017 · NS · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$467,319
R01 · FY2016 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$337,969
R01 · FY2016 · NS · contact PI
7th Intern Conf on AD and Related Disorders in the Middle East$50,000
R13 · FY2016 · AG · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$456,514
R01 · FY2015 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$337,969
R01 · FY2015 · NS · contact PI
Generation of High Passage and Immortalized Human Microglia Cell Lines$200,955
R21 · FY2015 · NS · contact PI
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates$460,543
R01 · FY2014 · AG
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype$337,969
R01 · FY2014 · NS · contact PI
Generation of High Passage and Immortalized Human Microglia Cell Lines$253,205
R21 · FY2014 · NS · contact PI
International Conf on Alzheimer Disease and Related Disorders in the Middle East$40,546
R13 · FY2013 · AG · contact PI
Fifth International Conference on Alzheimer's Disease in the ME$35,000
R13 · FY2009 · AG · contact PI
Isolation and Characterization of Cholinesterases From Plaques and Tangles$156,271
R21 · FY2008 · NS · contact PI
Isolation and Characterization of Cholinesterases From Plaques and Tangles$200,052
R21 · FY2007 · NS · contact PI
CaMKI, Apoptosis and Cholinergic Neurons in Aging and AD$64,513
R03 · FY2007 · AG · contact PI
CaMKI, Apoptosis and Cholinergic Neurons in Aging and AD$74,800
R03 · FY2006 · AG · contact PI
CALBINDIN AND CHOLINERGIC NEURONS IN AGING AND AD$284,993
R01 · FY2002 · AG
CALBINDIN AND CHOLINERGIC NEURONS IN AGING AND AD$276,695
R01 · FY2001 · AG
CALBINDIN AND CHOLINERGIC NEURONS IN AGING AND AD$268,633
R01 · FY2000 · AG